IBX 0.00% 3.6¢ imagion biosystems limited

Ann: Imagion to complete the MagSense HER2 Phase 1 Study, page-8

  1. 847 Posts.
    lightbulb Created with Sketch. 210
    Maybe the last couple years has left me pessimistic all things IBX but this announcement is frustrating.

    Announcement is about completing the phase 1 trial, however:
    -Not actually closing enrolment for another 6 weeks
    -If someone is enrolled in that last week or so it takes them a month to complete their testing, therefore the study wouldn't have actually wrapped up for another 10 weeks - then another 4-6 weeks to collate all the data.
    -Then there is an amendment to the phase 1 study enrolling one to two additional patients who need to have had a node dissection operation to then analyse the node under MRI

    Whenever Bob is quoted there is a sense of complete ignorance about what is going on and it is incredibly annoying.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
3.6¢
Change
0.000(0.00%)
Mkt cap ! $1.283M
Open High Low Value Volume
3.7¢ 3.7¢ 3.6¢ $505 14.03K

Buyers (Bids)

No. Vol. Price($)
1 9216 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.7¢ 9229 1
View Market Depth
Last trade - 16.10pm 26/08/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.